![Jeffrey Poulton](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jeffrey Poulton
Finansdirektör/CFO på
ALNYLAM PHARMACEUTICALS, INC.
Förmögenhet: 19 M $ per 2026-06-30
Profil
Jeffrey V.
Poulton is currently Non-Executive Director at EIP Pharma, Inc., Director at Alnylam UK Ltd. since 2019, Independent Director at CervoMed, Inc. since 2023, and Executive VP, Chief Financial & Accounting Officer at Alnylam Pharmaceuticals, Inc. since 2019.
Former roles include Chief Financial Officer & Executive Director at Shire Plc from 2015 to 2017, Independent Director at Homology Medicines, Inc. from 2020 to 2022, and Chief Financial Officer at Indigo Ag, Inc. from 2018 to 2019.
Education includes an undergraduate degree from Duke University and an MBA from Kelley School of Business.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-03-04 | 61 862 ( 0,05 % ) | 19 M $ | 2026-06-30 | |
CERVOMED INC. 0,12 % | 2026-06-08 | 16 444 ( 0,12 % ) | 50 976 $ | 2026-06-30 |
Aktiva positioner av Jeffrey Poulton
| Företag | Position | Start |
|---|---|---|
| ALNYLAM PHARMACEUTICALS, INC. | Finansdirektör/CFO | 2019-08-13 |
| CERVOMED INC. | Direktör/Styrelseledamot | 2023-08-16 |
EIP Pharma, Inc.
 EIP Pharma, Inc. BiotechnologyHealth Technology Operates as a clinical-stage company focused on developing treatments for neurodegenerative diseases | Direktör/Styrelseledamot | - |
Alnylam UK Ltd.
 Alnylam UK Ltd. BiotechnologyHealth Technology Develops biotechnology products | Direktör/Styrelseledamot | 2019-08-13 |
Tidigare kända positioner av Jeffrey Poulton
| Företag | Position | Slut |
|---|---|---|
Indigo Ag, Inc.
 Indigo Ag, Inc. Chemicals: AgriculturalProcess Industries Develops biological microbial seed treatments | Finansdirektör/CFO | 2019-04-01 |
| SHIRE | Finansdirektör/CFO | 2015-01-01 |
| Q32 BIO INC. | Direktör/Styrelseledamot | - |
Jeffrey Poultons utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
76
Första gradens relationer
9
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 9 |
|---|---|
Shire Plc
 Shire Plc Pharmaceuticals: MajorHealth Technology Develops and markets medicines for patients with rare diseases | Health Technology |
Duke University
 Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alnylam Pharmaceuticals, Inc.
 Alnylam Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics based on RNA interference | Health Technology |
Kelley School of Business
 Kelley School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Indigo Ag, Inc.
Indigo Ag, Inc. Chemicals: AgriculturalProcess Industries Develops biological microbial seed treatments | Process Industries |
EIP Pharma, Inc.
EIP Pharma, Inc. BiotechnologyHealth Technology Operates as a clinical-stage company focused on developing treatments for neurodegenerative diseases | Health Technology |
Homology Medicines, Inc.
 Homology Medicines, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage genetic medicines company | Health Technology |
Alnylam UK Ltd.
Alnylam UK Ltd. BiotechnologyHealth Technology Develops biotechnology products | Health Technology |
CervoMed, Inc.
 CervoMed, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biopharmaceutical company that develops novel therapies | Commercial Services |
